- Home
- CMCL vs FENC Comparison
CMCL vs FENC Comparison
Compare CMCL & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMCL
- FENC
- Stock Information
- Founded
- CMCL 1992
- FENC 1996
- Country
- CMCL Jersey
- FENC United States
- Employees
- CMCL N/A
- FENC N/A
- Industry
- CMCL Precious Metals
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CMCL Basic Materials
- FENC Health Care
- Exchange
- CMCL Nasdaq
- FENC Nasdaq
- Market Cap
- CMCL 586.0M
- FENC 225.4M
- IPO Year
- CMCL N/A
- FENC 2001
- Fundamental
- Price
- CMCL $31.83
- FENC $8.67
- Analyst Decision
- CMCL Strong Buy
- FENC Strong Buy
- Analyst Count
- CMCL 1
- FENC 2
- Target Price
- CMCL $28.00
- FENC $13.50
- AVG Volume (30 Days)
- CMCL 285.4K
- FENC 56.7K
- Earning Date
- CMCL 11-10-2025
- FENC 11-06-2025
- Dividend Yield
- CMCL 1.76%
- FENC N/A
- EPS Growth
- CMCL 432.25
- FENC N/A
- EPS
- CMCL 1.92
- FENC N/A
- Revenue
- CMCL $204,738,000.00
- FENC $33,302,000.00
- Revenue This Year
- CMCL $41.68
- FENC $0.18
- Revenue Next Year
- CMCL N/A
- FENC $52.59
- P/E Ratio
- CMCL $16.25
- FENC N/A
- Revenue Growth
- CMCL 28.06
- FENC N/A
- 52 Week Low
- CMCL $8.81
- FENC $3.96
- 52 Week High
- CMCL $33.50
- FENC $9.42
- Technical
- Relative Strength Index (RSI)
- CMCL 67.90
- FENC 48.25
- Support Level
- CMCL $26.26
- FENC $8.42
- Resistance Level
- CMCL $33.50
- FENC $9.11
- Average True Range (ATR)
- CMCL 1.48
- FENC 0.32
- MACD
- CMCL 0.30
- FENC -0.04
- Stochastic Oscillator
- CMCL 81.28
- FENC 29.14
About CMCL Caledonia Mining Corporation Plc
Caledonia Mining Corp PLC is a gold exploration, development, and mining company. The company's segment includes Blanket, South Africa, Bilboes Oxide mine, and E&E projects. The company generates the majority of its revenue from the Blanket project. The Blanket Mine is located in the south-west of Zimbabwe and operates at a depth of approximately 750 meters below the surface. The company's project includes Maligreen and Motapa.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.